Look for New GLP-1 Agonist and Flozin Options for Type 2 Diabetes

February 2018

You'll see more players join the crowded field of type 2 diabetes meds...Bydureon BCise, Ozempic (oh-ZEM-pik), Steglatro (steh-GLAH-troh).

Bydureon BCise (exenatide ER) and Ozempic (semaglutide) will bring the total to eight GLP-1 agonists. Both are once-WEEKLY injections.

Bydureon BCise is extended-release exenatide, like Bydureon. You'll hear it gives more consistent drug levels in a simpler pen device.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Diabetes Meds Look for New GLP-1 Agonist and Flozin Options for Type 2 Diabetes
Monitoring Compare Freestyle Libre and Other Continuous Glucose Monitors
Women's Health Ease Fears About Breast Cancer Risk With Hormonal Contraception
Supplements Be Aware That Biotin May Skew Lab Test Results
Cardiology Use "ABCDs" to Optimize Meds for Stable Coronary Artery Disease
Asthma Ensure Long-Acting Beta-Agonists Aren't Used Alone for Asthma
Travel Medicine Share Strategies to Limit Altitude Sickness
Psoriasis Know Key Points About Biologics for Psoriasis
HIV & AIDS Expect a Limited Role for the New HIV Drug, Juluca
Erectile Dysfunction Anticipate Interest in Generic Viagra (Sildenafil)
Practice Get Tools to Tackle This Flu Season